TMO logo

Thermo Fisher Scientific Inc. (TMO)

Profile

Full Name

Thermo Fisher Scientific Inc.

Ticker

NYSE: TMO

Exchange

NYSE

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

March 17, 1980

Indexes

S&P 500

Website

https://www.thermofisher.com

Employees

125000

Key Details

Price

$463.04(-0.99%)

Market cap

$174.79B(Mega cap)

Last Dividend

$0.43

TTM Dividend yield

0.35%

Annual revenue

$42.88B(+0.05% YoY)

Annual EPS

$16.53(+6.99% YoY)

PE ratio

26.78

Next earnings date

Oct 23, 2025

Next ex-dividend date

Sep 15, 2025

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $463.04
    TMO price is $463.04

    30-Day Relative Volume

    0.75
    TMO 30-day relative volume is 0.75

    Price Performance

    Price Most recent change

    -0.99%
    TMO price was down -0.99% on Aug 1, 2025

    Price YTD change

    -10.99%
    TMO price is down -10.99% since January 1st

    Price 1-year change

    -25.53%
    TMO price is down -25.53% year-on-year

    Price 3-year change

    -21.46%
    TMO price is down -21.46% over the past 3 years

    Price Range

    Price All-time high

    $672.34
    TMO price is currently -31.13% below its historical high of $672.34

    Price 3-year low

    $385.46
    TMO price is currently +20.13% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $174.79B
    TMO market capitalization is $174.79 billion

    Market cap 3-year change

    -24.32%
    TMO market capitalization is down -24.32% over the past 3 years

    Market cap All-time high

    $263.18B
    TMO market capitalization is currently -33.58% below its historical high of $263.18 billion

    Market cap sector rank

    99.26%
    TMO market capitalization is higher than 99.26% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -1.18%
    TMO shares outstanding is down -1.18% year-on-year

    Shares Outstanding 3-Year Change

    -3.65%
    TMO shares outstanding is down -3.65% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.83
    TMO beta is 0.83

    200-day SMA

    $491.66
    TMO price is currently -5.82% below its 200-day simple moving average

    50-day SMA

    $420.48
    TMO price is currently +10.12% above its 50-day simple moving average

    RSI

    59.40
    TMO 14-day relative strength index is 59.40

    Volume

    0.75
    TMO 30-day relative volume is 0.75

    ATR

    $14.28
    TMO average true range is $14.28

    10-day Historical Volatility

    57.70%
    TMO 10-day historical volatility is 57.70%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.43
    TMO last dividend was $0.43 per share, with an ex-dividend date of June 13, 2025

    Next Dividend

    $0.43
    TMO has announced a dividend of $0.43 per share, with an ex-dividend date set for September 15, 2025

    Dividend per share

    Dividend per share

    $1.56
    TMO annual dividend per share is $1.56

    Dividend per share Sector Rank

    59.3%
    TMO annual dividend per share is higher than 59.3% of companies in Healthcare sector

    Dividend per share 1-Year Change

    +11.43%
    TMO annual dividend per share is up +11.43% year-on-year

    Dividend per share 3-Year Change

    +50%
    TMO annual dividend per share is up +50% over the past 3 years

    Dividend yield

    Dividend yield

    0.34%
    TMO annual dividend yield is 0.34%

    Dividend yield Sector Rank

    8.24%
    TMO annual dividend yield is higher than 8.24% of companies in Healthcare sector

    Other

    Payout ratio

    9.20%
    TMO annual payout ratio is 9.20%

    Dividends paid

    $583.00M
    TMO annual dividends paid is $583.00 million

    Free cash flow

    $7.27B
    TMO annual free cash flow is $7.27 billion

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $42.88B
    TMO annual revenue is $42.88 billion

    Revenue Analysts estimate

    $43.88B
    TMO annual revenue is currently -2.28% lower than the consensus analysts' forecast

    Revenue 1-year change

    +0.05%
    TMO annual revenue is up +0.05% year-on-year

    Revenue Sector rank

    97.71%
    TMO annual revenue is higher than 97.71% of companies in Healthcare sector

    EPS

    EPS

    $16.53
    TMO annual earnings per share is $16.53

    EPS Analysts estimate

    $22.50
    TMO annual earnings per share is currently -26.54% lower than the consensus analysts' forecast

    EPS 1-year change

    +6.99%
    TMO annual earnings per share is up +6.99% year-on-year

    EPS Sector rank

    98.92%
    TMO annual earnings per share is higher than 98.92% of companies in Healthcare sector

    Profit

    Gross profit

    $18.06B
    TMO annual gross profit is $18.06 billion

    Gross margin

    42.12%
    TMO annual gross profit margin is 42.12%

    Operating profit

    $7.72B
    TMO annual operating income is $7.72 billion

    Operating margin

    17.99%
    TMO annual operating profit margin is 17.99%

    Net income

    $6.33B
    TMO annual net profit is $6.33 billion

    Net margin

    14.77%
    TMO annual net profit margin is 14.77%

    Expenses

    Total expenses

    $35.16B
    TMO annual total expenses is $35.16 billion

    Operating expenses

    $10.35B
    TMO annual total operating expenses is $10.35 billion

    Cost of goods sold

    $24.82B
    TMO annual cost of goods sold is $24.82 billion

    Selling, general & administrative expenses

    $7.00B
    TMO annual SGA is $7.00 billion

    Depreciation and amortization

    $3.11B
    TMO annual depreciation & amortization is $3.11 billion

    Interest expense

    $1.39B
    TMO annual interest expense is $1.39 billion

    Income tax

    $657.00M
    TMO annual income tax is $657.00 million

    EBIT & EBITDA

    EBIT

    $8.43B
    TMO annual earnings before interest & taxes is $8.43 billion

    EBITDA

    $11.54B
    TMO annual EBITDA is $11.54 billion

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $97.32B
    TMO annual total assets is $97.32 billion

    Non current assets

    $75.18B
    TMO annual long term assets is $75.18 billion

    Current assets

    $22.14B
    TMO annual total current assets is $22.14 billion

    Cash and cash equivalents

    $4.01B
    TMO annual cash & cash equivalents is $4.01 billion

    Accounts receivable

    $8.19B
    TMO annual accounts receivable is $8.19 billion

    Inventory

    $4.98B
    TMO annual inventory is $4.98 billion

    Liabilities

    Total liabilities

    $47.65B
    TMO annual total liabilities is $47.65 billion

    Long term liabilities

    $34.32B
    TMO annual total long term liabilities is $34.32 billion

    Current liabilities

    $13.33B
    TMO annual total current liabilities is $13.33 billion

    Accounts payable

    $3.08B
    TMO annual accounts payable is $3.08 billion

    Debt

    Total debt

    $31.27B
    TMO annual total debt is $31.27 billion

    Total debt 1-year change

    -10.43%
    TMO annual total debt is down -10.43% year-on-year

    Long term debt

    $29.06B
    TMO annual long term debt is $29.06 billion

    Short term debt

    $2.21B
    TMO annual short term debt is $2.21 billion

    Equity & Capital

    Shareholders equity

    $49.59B
    TMO annual stockholders equity is $49.59 billion

    Book value

    $49.55B
    TMO annual book value is $49.55 billion

    Retained earnings

    $53.10B
    TMO annual retained earnings is $53.10 billion

    Working capital

    $8.80B
    TMO annual working capital is $8.80 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $8.67B
    TMO annual cash flow from operations is $8.67 billion

    Cash from operations 1-year change

    +3.1%
    TMO annual cash flow from operations is up +3.1% year-on-year

    Cash from investing

    -$5.84B
    TMO annual cash flow from investing activities is -$5.84 billion

    Cash from investing 1-year change

    -13.59%
    TMO annual cash flow from investing activities is down -13.59% year-on-year

    Cash from financing

    -$6.79B
    TMO annual cash flow from financing activities is -$6.79 billion

    Cash from financing 1-year change

    -87.52%
    TMO annual cash flow from financing activities is down -87.52% year-on-year

    CAPEX

    CAPEX

    $1.40B
    TMO annual capital expenditures is $1.40 billion

    CAPEX 1-year change

    -5.34%
    TMO annual capital expenditures is down -5.34% year-on-year

    Free Cash Flow

    Free cash flow

    $7.27B
    TMO annual free cash flow is $7.27 billion

    Free cash flow 1-year change

    +4.91%
    TMO annual free cash flow is up +4.91% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    42.12%
    TMO annual gross profit margin is 42.12%

    Operating margin

    17.99%
    TMO annual operating profit margin is 17.99%

    Net margin

    14.77%
    TMO annual net profit margin is 14.77%

    ROA & ROE

    ROA

    6.46%
    TMO annual return on assets is 6.46%

    ROE

    13.13%
    TMO annual return on equity is 13.13%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    26.78
    TMO price to earnings ratio is 26.78

    PE ratio Sector rank

    55.5%
    TMO price to earnings ratio is higher than 55.5% of companies in Healthcare sector

    PB Ratio

    PB ratio

    3.46
    TMO price to book ratio is 3.46

    PB ratio Sector rank

    72.2%
    TMO price to book ratio is higher than 72.2% of companies in Healthcare sector

    PS Ratio

    PS ratio

    4.05
    TMO price to sales ratio is 4.05

    PS ratio Sector rank

    58%
    TMO price to sales ratio is higher than 58% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $205.45B
    TMO enterprise value is $205.45 billion

    Enterprise value Sector rank

    99.41%
    TMO enterprise value is higher than 99.41% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    18.24
    TMO EV/EBITDA is 18.24

    EV/EBITDA Sector rank

    91.34%
    TMO EV/EBITDA is higher than 91.34% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.66
    TMO annual current ratio is 1.66

    Quick ratio

    1.29
    TMO annual quick ratio is 1.29

    Leverage

    Debt to equity

    0.63
    TMO annual debt to equity ratio is 0.63

    Interest coverage ratio

    6.06
    TMO annual interest coverage ratio is 6.06

    Risk & Stability

    Piotroski F-Score

    6
    TMO piotroski f-score is 6

    Altman Z-Score

    3.80
    TMO altman z-score is 3.80

    Analyst ratings

    Recent major analysts updates

    Jul 24, 25 Wells Fargo
    Overweight
    Jul 24, 25 UBS
    Neutral
    Jul 24, 25 Raymond James
    Outperform
    Jul 24, 25 Barclays
    Equal-Weight
    Jul 24, 25 Baird
    Outperform
    Jul 18, 25 Baird
    Outperform
    Jul 11, 25 Scotiabank
    Sector Outperform
    Jul 9, 25 UBS
    Neutral
    Jul 8, 25 Evercore ISI Group
    Outperform
    Jun 24, 25 Barclays
    Equal-Weight

    Institutional Ownership

    Screeners with TMO included

    US stocks
    High Piotroski score stocks
    S&P 500 companies earnings calendar
    Stocks below SMA 200
    Most recommended stocks
    Best performing stocks last 3 months
    Best performing stocks last 5 years
    S&P 500 companies
    Stocks below analysts price target
    S&P 500 companies dividend calendar
    • What is the ticker symbol for Thermo Fisher Scientific Inc.?
    • Does Thermo Fisher Scientific Inc. pay dividends?
    • What sector is Thermo Fisher Scientific Inc. in?
    • What industry is Thermo Fisher Scientific Inc. in?
    • What country is Thermo Fisher Scientific Inc. based in?
    • When did Thermo Fisher Scientific Inc. go public?
    • Is Thermo Fisher Scientific Inc. in the S&P 500?
    • Is Thermo Fisher Scientific Inc. in the NASDAQ 100?
    • Is Thermo Fisher Scientific Inc. in the Dow Jones?
    • When was Thermo Fisher Scientific Inc.'s last earnings report?
    • When does Thermo Fisher Scientific Inc. report earnings?

    What is the ticker symbol for Thermo Fisher Scientific Inc.?

    The ticker symbol for Thermo Fisher Scientific Inc. is NYSE:TMO

    Does Thermo Fisher Scientific Inc. pay dividends?

    Yes, Thermo Fisher Scientific Inc. pays dividends. The last payment was $0.43, with an ex-dividend date on June 13, 2025

    What sector is Thermo Fisher Scientific Inc. in?

    Thermo Fisher Scientific Inc. is in the Healthcare sector

    What industry is Thermo Fisher Scientific Inc. in?

    Thermo Fisher Scientific Inc. is in the Diagnostics & Research industry

    What country is Thermo Fisher Scientific Inc. based in?

    Thermo Fisher Scientific Inc. is headquartered in United States

    When did Thermo Fisher Scientific Inc. go public?

    Thermo Fisher Scientific Inc.'s initial public offering (IPO) was on March 17, 1980

    Is Thermo Fisher Scientific Inc. in the S&P 500?

    Yes, Thermo Fisher Scientific Inc. is included in the S&P 500 index

    Is Thermo Fisher Scientific Inc. in the NASDAQ 100?

    No, Thermo Fisher Scientific Inc. is not included in the NASDAQ 100 index

    Is Thermo Fisher Scientific Inc. in the Dow Jones?

    No, Thermo Fisher Scientific Inc. is not included in the Dow Jones index

    When was Thermo Fisher Scientific Inc.'s last earnings report?

    Thermo Fisher Scientific Inc.'s most recent earnings report was on July 23, 2025

    When does Thermo Fisher Scientific Inc. report earnings?

    The next expected earnings date for Thermo Fisher Scientific Inc. is October 23, 2025
    On this page